By doing so, Food and Beverage facilities can lower their emissions related to waste by up to 90%. Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the pharmaceutical industry. In the United Kingdom, the National Health Service (NHS) has set a goal of achieving net-zero emissions by 2040, with a particular focus on reducing single-use plastics and improving waste management practices. The NHS’s “Clinical Waste Strategy” specifically calls for the adoption of innovative technologies to enable on-site treatment of biohazardous waste, reducing the need for transportation and off-site incineration. Peter brings significant experience in corporate finance, business development and financial management in both public and private life science companies. Peter is a non-executive director of Avadel Pharmaceuticals plc, a NASDAQ listed biopharmaceutical company, and Oculer Limited, a company developing and commercialising proprietary rapid microbiology technology.

Why choose Envetec?

The transition to more sustainable biohazardous waste management practices in the Food & Beverage industry not only aligns with environmental objectives but also presents economic opportunities. By doing so, Veterinary care pin up online casino facilities can lower their emissions related to waste by up to 90%. The veterinary science industry’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations and promoting a circular economy. For instance, the European Union’s Farm to Fork Strategy (2020) emphasizes the importance of sustainable food production systems, including responsible waste management practices along the entire supply chain.

Michael Dowling

The generated waste must be treated before disposal because it can cause illness, as well as environmental contamination and damage if left untreated. GENERATIONS® our innovative, clean technology helps life science meet their sustainability goals by transforming the treatment of biohazardous waste and enabling the plastic to be recycled. Globally, the management of biohazardous waste is subject to stringent regulations and guidelines set forth by organizations such as the Food and Agriculture Organization (FAO) and the Basel Convention. These frameworks aim to ensure the safe and responsible handling, treatment, and disposal of biohazardous materials, safeguarding both human health and the environment.

• Previously, he was CFO of Technopath Clinical Diagnostics (until its sale to LGC Group in 2021), a provider of quality control solutions to clinical laboratories worldwide.
• Sunny is a seasoned communications strategist who has worked in senior roles across diverse sectors, including healthcare, financial services, technology, and consumer.
• Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the veterinary science industry.
• Contact us to learn how GENERATIONS can help your veterinary facility transition to a sustainable biohazardous waste management solution, reducing environmental impact while unlocking economic opportunities through the circular economy and simultaneously eliminating the need to transport biohazardous waste from your facility.

Following this he joined Technopath Distribution in 2005 as a Technical Sales representative and ultimately covered roles of increasing responsibility before becoming Business Development Manager. In 2015 Paul joined IDEXX Laboratories where he was Sales Manager for Europe and various Distribution territories. His experience includes Pharma, Med-Device, Food And Beverage as well as extensive knowledge of the Veterinary sector. Paul is passionate about creating clean change and is confident that we can have positive environmental impact by responsible treatment of Laboratory Biohazardous waste.

This decarbonisation plan is in line with the Irish Government’s Climate Action Plan 2021 (Irish Government, 2021). Imogen spent her executive career in the fintech arena as Commercial Director of the London Stock Exchange and latterly President of two divisions of S&P Global. She brings global experience to the boards that she serves plus a strong commercial, client and talent-focused agenda while specialising in Remuneration Committee work on both listed and non-listed boards. While the mishandling or improper disposal of biohazardous waste can lead to the spread of foodborne illnesses and environmental contamination, the impact of traditional disposal methods on the environment is also extremely detrimental. GENERATIONS is helping the largest private hospital group in New York State treat their regulated medical waste sustainably and can also help your healthcare facility to achieve its sustainability goals. He established W2 over 25 years ago, creating a group of businesses that support marketing & strategic planning, leadership development, client acquisition.

The latest science and technology news from Ireland

Extended life expectancy as well as improving quality of life has been the direct result of improved therapeutics in almost all facets of life. Envetec GENERATIONS is an on-site, non-thermal, Clean Technology that treats biohazardous waste onsite in a quick, effective and sustainable way. Mr Kenny (71), who was taoiseach from 2011 to 2017, is one of five recent appointments to the board of the cleantech business, which has raised €10 million in new funding to support its growth. Mr Kenny has secured a number of directorships since stepping down as taoiseach, including with Heneghan, the Ireland China Institute and Carbon Collect Ltd.

Benefits of Our Technology

In 2014, he spun out two companies from Technopath – ValitaCell Ltd and Oculer Ltd, respectively. Within 12 months, he created a five-year strategic roadmap to support critical funding initiatives, including evaluating the Health System’s existing investment portfolio, investment companies, and joint ventures alongside introducing a new operating model and organizational structure. Malcolm earned his undergraduate degree in molecular biology and his master’s degree in biotechnology from the National University of Ireland. The transition to more sustainable biohazardous waste management practices in the veterinary science industry not only aligns with environmental objectives but also presents economic opportunities. By embracing innovative technologies that enable the recovery and reuse of valuable materials from waste streams, facilities can realize cost savings, improve resource efficiency, and contribute to the development of a circular economy.

Employees at Envetec Sustainable Technologies

Previously, he was CFO of Technopath Clinical Diagnostics (until its sale to LGC Group in 2021), a provider of quality control solutions to clinical laboratories worldwide. Peter has served as a non-executive director of both public and private companies including Leon-Nanodrugs GmbH, Valitacell Limited, Merrion Pharmaceuticals plc, Cydex Pharmaceuticals Inc. and Antigenics Inc. Peter worked for the international public accounting firm of KPMG in Ireland and France and is a fellow of Chartered Accountants Ireland and a member of the Institute of Directors. Contact us to learn how GENERATIONS can help your veterinary facility transition to a sustainable biohazardous waste management solution, reducing environmental impact while unlocking economic opportunities through the circular economy and simultaneously eliminating the need to transport biohazardous waste from your facility. Globally, the management of biohazardous waste is subject to stringent regulations and guidelines set forth by organizations such as the World Organisation for Animal Health (OIE) and the Basel Convention. These frameworks aim to ensure the safe and responsible handling, treatment, and disposal of biohazardous materials, safeguarding both human and animal health while minimizing environmental impacts.

• Traditionally, the treatment of veterinary biohazardous waste has relied heavily on incineration, a process that effectively neutralizes the hazardous properties of the waste but contributes significantly to greenhouse gas emissions and air pollution.
• This novel validation system validates the efficacy of the GENERATIONS process during live waste processing ensuring the highest level of confidence in the efficacy.
• She brings global experience to the boards that she serves plus a strong commercial, client and talent-focused agenda while specialising in Remuneration Committee work on both listed and non-listed boards.
• By eliminating high-carbon transportation and thermal treatments, GENERATIONS enables medical technology facilities to recycle waste that would otherwise end up in landfills.
• By aligning environmental stewardship with economic interests, the industry can foster a sustainable approach to biohazardous waste management that safeguards public health, protects the environment, and supports long-term business resilience.

What Scope Does Waste Belong to?Read More

W2 is a blend of his experience in international sport, broadcasting and business, built on an understanding of success and failure in high performing teams and individuals. Investor wise, Keith has followed his interests, from media to property, from sports science to rural regeneration, from healthy ageing to lifestyle businesses.Keith captained the Irish Rugby Team 36 times, toured with the Lions twice, and is the inaugural winner of the World Player of the Year in 2001. Keith has worked extensively in journalism and media, writing for The Times, The Daily Telegraph, and Independent News as well as broadcasting for the BBC and Newstalk.

The pharmaceutical industry generates substantial volumes of biohazardous waste as a byproduct of research, development, and manufacturing activities. This category of waste, which includes infectious materials, toxins, and other hazardous substances, presents unique challenges that necessitate stringent management protocols to safeguard public health and the environment. Sunny is a seasoned communications strategist who has worked in senior roles across diverse sectors, including healthcare, financial services, technology, and consumer. The healthcare sector, whose mission is protecting people and promoting health, makes a major contribution to the climate crisis. Changes to the climate and to the environment have direct and immediate consequences for patients, the public and for health systems in general.

This collaboration will enable healthcare and life science organisations to meet their sustainability goals by significantly reducing their carbon footprint and water usage. Contact us to learn how GENERATIONS can help your facility transition to a sustainable biohazardous waste management solution, reducing environmental impact while unlocking economic opportunities through the circular economy. Facilities adopting Envetec’s GENERATIONS®   clean technology for onsite treatment of biohazardous waste will now benefit from Enva’s advanced waste management solutions, including the collection and recycling of the treated material.

Facilities can now send material to be recycled that otherwise would end up in landfill and/or incinerated. The transition to more sustainable biohazardous waste management practices not only aligns with environmental objectives but also presents economic opportunities for pharmaceutical companies. By embracing innovative technologies that enable the recovery and reuse of valuable materials from waste streams, companies can realize cost savings. For example, recovering high value polymers from what is typically considered waste can significantly reduce the need for purchasing virgin materials, improving resource efficiency. As the Food & Beverage industry continues to prioritize sustainability and responsible waste management, the adoption of disruptive technologies that effectively treat biohazardous waste while minimizing environmental impact will become increasingly essential. By aligning environmental stewardship with economic interests, the industry can foster a sustainable approach to biohazardous waste management that safeguards public health, protects the environment, and supports long-term business resilience.

Malcolm Bell serves as Chief Executive Officer of Envetec Sustainable Technologies, Ireland’s first cleantech company focused on breakthrough innovations to treat and repurpose biohazardous waste materials on-site, significantly reducing dependency on landfills, incineration and autoclaving. Addressing the growing urgency to achieve a substantive path toward net-zero from the diagnostic, healthcare, and food and beverage industries, Malcolm established Envetec as a standalone business in 2021. He served as CEO and oversaw the successful acquisition of the company to LGC in 2020.Malcolm has a track record of creating significant value by advancing assets, intellectual property, technology, and product portfolios.